We have collected information about Alza Drug Delivery Technology for you. Follow the links to find out details on Alza Drug Delivery Technology.
https://www.alzet.com/company/
Progress in drug delivery technology pioneered at ALZA Corporation leads to the development of ALZET Osmotic Pumps 1976 First publication describing the osmotic pump technology
https://thisisargus.com/portfolio-item/alzacorp/
ALZA Corporation was a pharmaceutical and medical systems company founded in 1968 by Dr Alejandro Zaffaroni. The company’s name is a portmanteau of his name. ALZA pioneered the field of drug delivery systems, bringing over 20 prescription pharmaceutical products to market. ALZA was acquired by Johnson & Johnson.
https://www.latimes.com/archives/la-xpm-1999-jun-22-fi-48933-story.html
Earlier this year, Alza completed its acquisition of Sequus Pharmaceuticals in Menlo Park. That company developed a technology for encapsulating a variety of drug products in fats for slow delivery...
https://www.pharmaceuticalonline.com/doc/connetics-alza-enter-drug-delivery-collaborat-0001
Alza's unique DUROS Osmotic Implant is a non-biodegradable and osmotically-driven technology that can be used to deliver small drugs, peptides, proteins, genes or other bioactive macromolecules for up to one year of continuous therapy. The implant is a small titanium alloy cylinder.
https://www.marketwatch.com/story/johnson-johnson-confirms-alza-deal
Mar 27, 2001 · Alza also brings the urinary incontinence drug Ditropan and the Attention Deficit Hyperactivity Disorder drug Concerta, among other products, to the merger. The two companies co-market Concerta. Alza also has a full pipeline of drug-delivery technology, including platforms for cancer, pain and anxiety.
https://pubsapp.acs.org/cen/coverstory/7838/7838scit1.html
Alza is also developing what it calls Macroflux technology, which incorporates a thin titanium screen with microprojections to create mechanical pathways for drug transport. It expands the range of drugs amenable to transdermal delivery to include small hydrophilic molecules and macromolecules.
https://www.zosanopharma.com/technology/
Intracutaneous delivery allows systemic drug delivery without the use of a hypodermic needle. In clinical studies, less than 10% of patients reported any pain at the application site. Pharmacokinetic analysis demonstrated ~ 3-times faster absorption of zolmitriptan using our system compared with orally administered zolmitriptan.
Searching for Alza Drug Delivery Technology?
You can just click the links above. The data is collected for you.
